Literature DB >> 19892798

MMP13 as a stromal mediator in controlling persistent angiogenesis in skin carcinoma.

Wiltrud Lederle1, Bettina Hartenstein, Alice Meides, Heike Kunzelmann, Zena Werb, Peter Angel, Margareta M Mueller.   

Abstract

Matrix metalloproteinases (MMPs) such as MMP13 promote tumour growth and progression by mediating extracellular matrix (ECM) reorganization and regulating the biological activity of cytokines. Using Mmp13-/- mice, we demonstrate an essential role of this single collagenase for highly malignant and invasive growth in skin squamous cell carcinoma (SCC). Lack of host MMP13 strongly impaired tumour growth of malignant SCC cells, leading to small, mostly avascular cysts. While initial stromal activation in tumour transplants of Mmp13+/+ and Mmp13-/- animals was similar, MMP13 was essential for maintenance of angiogenesis and for invasion. MMP13 was induced in fibroblasts of the wild-type animals at the onset of invasion and correlated with a strong increase in vascular endothelial growth factor (VEGF) protein and its association with vascular endothelial growth factor receptor-2 on endothelial cells in invasive areas. In contrast, VEGF protein in the stroma was barely detectable and tumour invasion was downregulated in Mmp13-/- animals, despite ongoing VEGF messenger RNA expression. Taken together with in vitro data showing the release of VEGF from the ECM by MMP13 expressing fibroblasts, these data strongly suggest a crucial role of MMP13 in promoting angiogenesis via releasing VEGF from the ECM and thus allowing the invasive growth of the SCC cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19892798      PMCID: PMC2893794          DOI: 10.1093/carcin/bgp248

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  54 in total

1.  A new mathematical model for relative quantification in real-time RT-PCR.

Authors:  M W Pfaffl
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

Review 2.  New functions for the matrix metalloproteinases in cancer progression.

Authors:  Mikala Egeblad; Zena Werb
Journal:  Nat Rev Cancer       Date:  2002-03       Impact factor: 60.716

3.  Characteristics of chemically transformed mouse epidermal cells in vitro and in vivo.

Authors:  N E Fusenig; S M Amer; P Boukamp; P K Worst
Journal:  Bull Cancer       Date:  1978       Impact factor: 1.276

Review 4.  Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets.

Authors:  Pia Vihinen; Veli-Matti Kähäri
Journal:  Int J Cancer       Date:  2002-05-10       Impact factor: 7.396

5.  High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma.

Authors:  Johanna Nikkola; Pia Vihinen; Meri-Sisko Vuoristo; Pirkko Kellokumpu-Lehtinen; Veli-Matti Kähäri; Seppo Pyrhönen
Journal:  Clin Cancer Res       Date:  2005-07-15       Impact factor: 12.531

Review 6.  Strategies for MMP inhibition in cancer: innovations for the post-trial era.

Authors:  Christopher Mark Overall; Carlos López-Otín
Journal:  Nat Rev Cancer       Date:  2002-09       Impact factor: 60.716

7.  pH regulates vascular endothelial growth factor binding to fibronectin: a mechanism for control of extracellular matrix storage and release.

Authors:  Adrienne L Goerges; Matthew A Nugent
Journal:  J Biol Chem       Date:  2003-10-21       Impact factor: 5.157

8.  Comparison of mouse matrix metalloproteinase 13 expression in free-electron laser and scalpel incisions during wound healing.

Authors:  Nanjun Wu; E Duco Jansen; Jeffrey M Davidson
Journal:  J Invest Dermatol       Date:  2003-10       Impact factor: 8.551

Review 9.  Matrix metalloproteinases in tumor-host cell communication.

Authors:  Conor C Lynch; Lynn M Matrisian
Journal:  Differentiation       Date:  2002-12       Impact factor: 3.880

10.  Collagenolysis-dependent angiogenesis mediated by matrix metalloproteinase-13 (collagenase-3).

Authors:  Andries Zijlstra; Ronald T Aimes; Dan Zhu; Karine Regazzoni; Tatyana Kupriyanova; Marco Seandel; Elena I Deryugina; James P Quigley
Journal:  J Biol Chem       Date:  2004-04-05       Impact factor: 5.157

View more
  53 in total

Review 1.  Insidious changes in stromal matrix fuel cancer progression.

Authors:  Fayth L Miles; Robert A Sikes
Journal:  Mol Cancer Res       Date:  2014-01-22       Impact factor: 5.852

2.  FSP1+ fibroblasts promote skin carcinogenesis by maintaining MCP-1-mediated macrophage infiltration and chronic inflammation.

Authors:  Jinhua Zhang; Lin Chen; Mingjie Xiao; Chunhui Wang; Zhihai Qin
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

Review 3.  Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature.

Authors:  Elena I Deryugina; James P Quigley
Journal:  Matrix Biol       Date:  2015-04-22       Impact factor: 11.583

4.  The role of stromal myofibroblast and extracellular matrix in tumor angiogenesis.

Authors:  Sylvia Vong; Raghu Kalluri
Journal:  Genes Cancer       Date:  2011-12

5.  Cancer associated fibroblasts: the dark side of the coin.

Authors:  Paolo Cirri; Paola Chiarugi
Journal:  Am J Cancer Res       Date:  2011-03-12       Impact factor: 6.166

Review 6.  Cell-extracellular matrix interactions in normal and diseased skin.

Authors:  Fiona M Watt; Hironobu Fujiwara
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-04-01       Impact factor: 10.005

7.  Matrix metalloproteinase-13 (MMP-13) directly and indirectly promotes tumor angiogenesis.

Authors:  Yasusei Kudo; Shinji Iizuka; Maki Yoshida; Takaaki Tsunematsu; Tomoyuki Kondo; Ajiravudh Subarnbhesaj; Elsayed M Deraz; Samadarani B S M Siriwardena; Hidetoshi Tahara; Naozumi Ishimaru; Ikuko Ogawa; Takashi Takata
Journal:  J Biol Chem       Date:  2012-09-19       Impact factor: 5.157

8.  Optical tomography of MMP activity allows a sensitive noninvasive characterization of the invasiveness and angiogenesis of SCC xenografts.

Authors:  Wa'el Al Rawashdeh; Susanne Arns; Felix Gremse; Josef Ehling; Ruth Knüchel-Clarke; Stefan Kray; Felix Spöler; Fabian Kiessling; Wiltrud Lederle
Journal:  Neoplasia       Date:  2014-03       Impact factor: 5.715

9.  Matrix metalloproteinase-13 mediated degradation of hyaluronic acid-based matrices orchestrates stem cell engraftment through vascular integration.

Authors:  Amit K Jha; Kevin M Tharp; Shane Browne; Jianqin Ye; Andreas Stahl; Yerem Yeghiazarians; Kevin E Healy
Journal:  Biomaterials       Date:  2016-03-03       Impact factor: 12.479

10.  Bone marrow-derived myofibroblasts are the providers of pro-invasive matrix metalloproteinase 13 in primary tumor.

Authors:  Julie Lecomte; Anne Masset; Silvia Blacher; Ludovic Maertens; André Gothot; Marie Delgaudine; Françoise Bruyère; Oriane Carnet; Jenny Paupert; Martin Illemann; Jean-Michel Foidart; Ida K Lund; Gunilla Høyer-Hansen; Agnes Noel
Journal:  Neoplasia       Date:  2012-10       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.